Literature DB >> 23660658

A mini-IRES sequence for stringent selection of high producers.

Jun Yan1, Hailin Yang, Guohua Yue, Wenda Gao.   

Abstract

Internal Ribosome Entry Site (IRES) sequences have been widely used to link the expression of two independent proteins on the same mRNA transcript. Genes encoding fluorescent proteins or drug-resistance enzymes are usually placed downstream of IRES, serving as expression indicators or selection markers. In biological applications where the upstream gene-of-interest is to be expressed at extremely high levels, it is often desirable to purposely reduce IRES downstream gene expression to economize the cellular resources and/or to generate more stringent selection pressure. Here we describe a miniature IRES mutant sequence (IRESmut3) with dramatically diminished co-translational efficiency to fulfill these purposes.

Mesh:

Substances:

Year:  2013        PMID: 23660658     DOI: 10.1007/s12038-013-9323-x

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  12 in total

1.  IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector.

Authors:  H Mizuguchi; Z Xu; A Ishii-Watabe; E Uchida; T Hayakawa
Journal:  Mol Ther       Date:  2000-04       Impact factor: 11.454

2.  Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide.

Authors:  Pablo de Felipe; Lorraine E Hughes; Martin D Ryan; Jeremy D Brown
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

Review 3.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

Review 4.  Development of 2A peptide-based strategies in the design of multicistronic vectors.

Authors:  Andrea L Szymczak; Dario A A Vignali
Journal:  Expert Opin Biol Ther       Date:  2005-05       Impact factor: 4.388

5.  Stable antibody expression at therapeutic levels using the 2A peptide.

Authors:  Jianmin Fang; Jing-Jing Qian; Saili Yi; Thomas C Harding; Guang Huan Tu; Melinda VanRoey; Karin Jooss
Journal:  Nat Biotechnol       Date:  2005-04-17       Impact factor: 54.908

6.  Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector.

Authors:  Y Zhou; J Aran; M M Gottesman; I Pastan
Journal:  Hum Gene Ther       Date:  1998-02-10       Impact factor: 5.695

7.  A noncytotoxic DsRed variant for whole-cell labeling.

Authors:  Rita L Strack; Daniel E Strongin; Dibyendu Bhattacharyya; Wen Tao; Allison Berman; Hal E Broxmeyer; Robert J Keenan; Benjamin S Glick
Journal:  Nat Methods       Date:  2008-10-26       Impact factor: 28.547

8.  Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.

Authors:  M D Ryan; A M King; G P Thomas
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

Review 9.  Exploiting internal ribosome entry sites in gene therapy vector design.

Authors:  S M Ngoi; A C Chien; C G L Lee
Journal:  Curr Gene Ther       Date:  2004-03       Impact factor: 4.391

10.  Development of a new bicistronic retroviral vector with strong IRES activity.

Authors:  Patrick Martin; Olivier Albagli; Marie Christine Poggi; Kim E Boulukos; Philippe Pognonec
Journal:  BMC Biotechnol       Date:  2006-01-12       Impact factor: 2.563

View more
  1 in total

1.  Human rhinovirus internal ribosome entry site element enhances transgene expression in transfected CHO-S cells.

Authors:  Yu-Rong Chai; Meng-Meng Ge; Ting-Ting Wei; Yan-Long Jia; Xiao Guo; Tian-Yun Wang
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.